综合回顾 基因素乳化:结构,功能和治疗点
Kaiwen Xu1, Keyi Zhang1, Yanshuang Wang2
1Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China.
Biochemical pharmacology
|May 31, 2024
概括
基因素 lysine 乳化 (Kla) 是一种新的表观遗传标记,影响基因表达和细胞代谢. 这种修改与癌症和神经退行等疾病有关,提供了新的治疗点.
科学领域:
- 表观遗传学和分子生物学
- 生物化学 生化学
- 细胞的新陈代谢
背景情况:
- 基因组 lysine 乳化 (Kla) 是一种独特的表观遗传修饰,涉及向 lysine 残留物添加乳基.
- 与其他化修饰不同,Kla会影响核细胞结构,染色体动态和基因表达.
- 克拉在细胞代谢,炎症反应和胚胎发育中起着至关重要的作用.
研究的目的:
- 为了区分基因组Kla与其他化修饰.
- 阐明基因素Kla在各种疾病中的机制和作用.
- 确定Kla相关疾病的潜在治疗点和现有药物.
主要方法:
- 文献综述和综合关于氨酸乳酸基的现有研究.
- 对Kla与其他基因素化标记进行比较分析.
- 探索Kla在代谢重编程和疾病发病过程中的参与.
主要成果:
- 希斯Kla与代谢重编程有显著的关联,特别是糖解和谷氨酸代谢.
- 克拉有助于瘤形成,免疫逃避和癌细胞组织中的血管生成.
- 基因组Kla与癌症和神经退行性疾病的发病有关.
结论:
- 基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因基因.
- 了解Kla在疾病中的作用,打开了新的治疗途径.
- 针对特定的Kla站点提供了新药开发的潜力.
相关概念视频
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Histone Modification
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Writers
The writer is an enzyme that can...
Histone Variants at the Centromere
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Histone Modification
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...


